Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.
Rusconi C, Barone A, Visentin A, Bianchi B, Zilioli VR, Bernardelli A, Iadecola S, Olivari E, Rossi FG, Gotti M, Cecchetti C, Puccini B, Franceschetti S, Molteni A, Steffanoni S, Marino F, Vanazzi A, Guidetti A, Merli M, Mazzon F, Marchetti A, Cellini A, Muzi C, Miceli R, Visco C, Re A, Corradini P. Rusconi C, et al. Among authors: bianchi b. Leuk Lymphoma. 2025 Jan 11:1-9. doi: 10.1080/10428194.2024.2446609. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39797589
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma.
Merli M, Defrancesco I, Visco C, Besson C, Di Rocco A, Arcari A, Sica A, Cencini E, Tisi MC, Frigeni M, Grossi P, Bianchi B, Mora B, Bertù L, Bruno R, Passamonti F, Arcaini L. Merli M, et al. Among authors: bianchi b. Leuk Lymphoma. 2020 Sep;61(9):2122-2128. doi: 10.1080/10428194.2020.1755859. Epub 2020 Apr 28. Leuk Lymphoma. 2020. PMID: 32343165
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas.
Merli M, Marino D, Cencini E, Rattotti S, Fraenza C, Grossi P, Bianchi B, Mora B, Sciarra R, Finotto S, Mecacci B, Passamonti F, Visco C, Arcaini L. Merli M, et al. Among authors: bianchi b. Hematol Oncol. 2021 Apr;39(2):263-266. doi: 10.1002/hon.2825. Epub 2020 Nov 20. Hematol Oncol. 2021. PMID: 33150988 No abstract available.
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Luminari S, Merli M, Rattotti S, Tarantino V, Marcheselli L, Cavallo F, Varettoni M, Bianchi B, Merli F, Tedeschi A, Cabras G, Re F, Visco C, Torresan Delamain M, Cencini E, Spina M, Ferrero S, Ferrari A, Deodato M, Mannina D, Annibali O, Rago A, Orsucci L, Defrancesco I, Frigeni M, Cesaretti M, Arcaini L. Luminari S, et al. Among authors: bianchi b. Blood. 2019 Sep 5;134(10):798-801. doi: 10.1182/blood.2019001088. Epub 2019 Jul 10. Blood. 2019. PMID: 31292118 Free article.
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
Merli M, Luminari S, Farina L, Cocito F, Defrancesco I, Gini G, Arcari A, Scapinello G, Gentile M, Goldaniga M, Loseto G, Cencini E, Greco A, Molinari AL, Ferrario A, Bianchi B, Mora B, Bertù L, Saturni V, Bergamini F, Fabbri N, Rossi FG, Bolis S, Passamonti F, Arcaini L. Merli M, et al. Among authors: bianchi b. Bone Marrow Transplant. 2020 Dec;55(12):2350-2353. doi: 10.1038/s41409-020-0967-5. Epub 2020 Jun 15. Bone Marrow Transplant. 2020. PMID: 32541690 No abstract available.
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection.
Sciarra R, Merli M, Cristinelli C, Lucioni M, Zibellini S, Riboni R, Furlan D, Uccella S, Zerbi C, Bianchi B, Gotti M, Ferretti VV, Varraso C, Fraticelli S, Lazic T, Defrancesco I, Mora B, Libera L, Mazzacane A, Carpi F, Berliner M, Neri G, Rizzo E, De Paoli F, Sessa F, Passamonti F, Paulli M, Arcaini L. Sciarra R, et al. Among authors: bianchi b. Br J Haematol. 2024 Jun;204(6):2242-2253. doi: 10.1111/bjh.19378. Epub 2024 Mar 5. Br J Haematol. 2024. PMID: 38442902
Early progression beyond first-line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study.
Bavieri A, Nizzoli ME, Tucci A, Zilioli VR, Olivieri J, Bianchi B, Rosaria MG, Annibali O, Bari A, Casaluci GM, Cimminiello M, Di Renzo N, Cavallo F, Pavone V, Mannarella C, Arcari A, Alessandro M, Anastasia A, Tarantino V, Neri A, Gentile M, Morabito F, Luminari S. Bavieri A, et al. Among authors: bianchi b. Hemasphere. 2024 Dec 10;8(12):e70049. doi: 10.1002/hem3.70049. eCollection 2024 Dec. Hemasphere. 2024. PMID: 39698333 Free PMC article. No abstract available.
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type.
Lazzari L, Farina F, Lupo Stanghellini MT, Piemontese S, Marktel S, Mazzi B, Vago L, Milani R, Ferrario A, Bianchi B, Merli M, Ferreri AJM, Corti C, Peccatori J, Ruggeri A, Ciceri F. Lazzari L, et al. Among authors: bianchi b. Curr Res Transl Med. 2021 Oct;69(4):103313. doi: 10.1016/j.retram.2021.103313. Epub 2021 Sep 28. Curr Res Transl Med. 2021. PMID: 34598023 No abstract available.
329 results